To better understand the correlation between Znf179 gene expression and survival rates in patients with different-grade gliomas, cohorts of 52 low-grade II glioma patients (TCGA) (Fig. 5C,D) and 41 malignant grade IV GBM patients (GSE42669) (Fig. 5E,F) were analyzed using a Kaplan-Meier survival analysis. The gene discussed is RNF112; the disease is central nervous system cancer.